The review covered more than 17 million people vaccinated in the European Union and United Kingdom. “A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis… Read More »
However, the European Medicines Agency (EMA) said on Thursday there is no indication the vaccine has caused these symptoms. The EMA said in a statement: “There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. “The vaccine’s benefits continue to outweigh its risks and… Read More »
The decision to temporarily pause the rollout of the AstraZeneca/Oxford COVID-19 vaccine in Denmark due to reports of blood clots has sparked widespread panic. However, as of yet, there is no proven link between the two. In response to the news, Dr Phil Bryan, Medicines and Healthcare products Regulatory Agency (MRHA), Vaccines Safety Lead said:… Read More »
Pharmaceutical company AstraZeneca will put an experimental coronavirus vaccine study on hold in America after a participant in the United Kingdom faced an apparent serious adverse reaction, according to a report. The Anglo-Swedish company’s “standard review process triggered a pause to vaccination to allow review of safety data,” an AstraZeneca spokesperson said. CORONAVIRUS: WHAT YOU NEED TO KNOW… Read More »